Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Klotho Neurosciences Stock Price, Quotes and Forecasts | NASDAQ:KLTO | Benzinga

Q: What sector and industry does Klotho Neurosciences (KLTO) operate in?

Klotho Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Klotho Neurosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KLTO.

Open	-
Close	-
Volume / Avg.	19.65M / 28.16M
Day Range	- - -
52 Wk Range	0.11 - 5.11
Market Cap	$97.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	98
Short Interest	10.25%
Days to Cover	1

Recent News

Klotho Neurosciences, AMD, Strategy, Circle Internet Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks experienced a mixed session today, with the Dow Jones Industrial Average unchanged at 42,761.76 and the S&P 500 moving nearly 0.1% higher at 6,005.88. The Nasdaq rose 0.3% to 19,591.24 on Monday. These are the top stocks that gained the attention of retail traders and investors throughout the day:

Shivdeep Dhaliwal

Crude Oil Moves Higher; Graham Shares Surge After Q4 Results

Avi Kapoor

Klotho Neurosciences (KLTO) Stock Surges Over 680%: What's Going On?

Shares of Klotho Neurosciences skyrocketed over 500% after announcing promising new study findings. Its licensed therapy shows potential to reduce age-related degeneration and significantly increase healthy lifespan.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	19.65M / 28.16M
Day Range	- - -
52 Wk Range	0.11 - 5.11
Market Cap	$97.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	98
Short Interest	10.25%
Days to Cover	1

About Klotho Neurosciences Inc.

Sector

Health Care

Industry

Biotechnology

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Klotho Neurosciences (KLTO) stock?

You can purchase shares of Klotho Neurosciences (NASDAQ:KLTO) through any online brokerage.

View our list of the best stock brokerages

Who are Klotho Neurosciences (KLTO) competitors?

Other companies in Klotho Neurosciences’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Kalaris Therapeutics (NASDAQ:KLRS), Fortress Biotech (NASDAQ:FBIO) and Adverum Biotechnologies (NASDAQ:ADVM).

What is the forecast, or price target, for Klotho Neurosciences (KLTO) stock?

There is no analysis for Klotho Neurosciences to provide a consensus price target.

What is the current price for Klotho Neurosciences (KLTO)?

The stock price for Klotho Neurosciences (NASDAQ: KLTO) is $2.99 last updated June 10, 2025 at 4:43 AM EDT.

Does Klotho Neurosciences (KLTO) pay a dividend?

There are no upcoming dividends for Klotho Neurosciences.

When is Klotho Neurosciences (NASDAQ:KLTO) reporting earnings?

Klotho Neurosciences’s Q2 earnings are confirmed for Friday, August 15, 2025.

Is Klotho Neurosciences (KLTO) going to split?

There is no upcoming split for Klotho Neurosciences.

What sector and industry does Klotho Neurosciences (KLTO) operate in?

Klotho Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Klotho Neurosciences Stock Price, Quotes and Forecasts

Klotho Neurosciences (KLTO) Forecast